A state appeals court has upheld the dismissal of Pennsylvania’s lawsuit against Johnson & Johnson over allegations that the company improperly marketed its antipsychotic drug Risperdal, the Wall Street Journal reports.
Pennsylvania prosecutors had filed suit against J&J in 2007, trying to recover expenses incurred by the state’s Medicaid program for reimbursing pharmacies over the purchase of Risperdal. Prosecutors alleged that J&J had promoted Risperdal for unapproved – or “off-label” – ...
continue reading...
According to a report on TheHeart.org, the U.S. Food and Drug Administration (FDA) has approved a new vena cava filter made by Crux Biomedical of California.
Christine Scott, a woman awarded $5.5 million for injuries from a transvaginal mesh implant, said she hopes the development will help “get the word out to women,” according to a report on KGET out of California.
Blood clots in the deep leg veins – a condition called deep vein thrombosis — can be deadly if the clots break off and travel to the heart, lungs or brain. But according to a health column in the Herald Times Reporter in Wisconsin, the blood clots can cause lasting health problems even if they remain in the legs.
According to a report in U.S. News and World Report, people who have total hip or knee replacement surgery are about 30 times more likely to have a heart attack in the two weeks after the procedure.
